Light therapy for mild to moderate Alzheimer's disease
Part of Brain & nervous system clinical trials.
This study tests a near-infrared light therapy device for people with mild to moderate Alzheimer's disease. It may help with memory and thinking by using light on the head, a non-invasive approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50 to 85 years old.
- Have at least 4 years of formal education.
- Memory decline for at least 1 year before joining.
- Diagnosed with mild to moderate Alzheimer's disease (stages 4-5).
- Evidence of amyloid in the brain from a PET scan or spinal fluid test.
- Able to have a partner who can come with you daily and help with the study.
- If taking Alzheimer's medications, must be on a stable dose for at least 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special near-infrared light device, combined with the medication lecanemab, can help people with mild Alzheimer's disease. It aims to see if the light therapy can slow down memory loss and improve daily function.
This study tests whether shining a special near-infrared light on the head can help people with mild to moderate Alzheimer's disease. The light is thought to improve brain cell function and reduce damage.
This trial tests whether a gentle, non-invasive brain stimulation (transcranial alternating current) can improve memory and thinking in people with early Alzheimer's or mild memory problems. It involves regular sessions of stimulation and check-ups over several months.
This study tests whether a non-invasive 40 Hz light therapy system can help people with early Alzheimer’s. You’ll likely use the device at home and wear a small activity monitor, while doing memory and thinking tests.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
This study tests whether shining a gentle infrared light on the head can help people with mild memory loss (MCI) improve their thinking and memory. It is designed for those who have mild cognitive impairment due to early Alzheimer's disease.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.